Abstract:This article describes an electrospinning process to fabricate double-layered ultrafine fibers. A bioabsorbable polymer, Polycaprolactone (PCL), was used as the outer layer or the shell and two medically pure drugs, Resveratrol (RT, a kind of antioxidant) and Gentamycin Sulfate (GS, an antibiotic), were used as the inner layers or the cores. Morphology and microstructure of the ultrafine fibers were characterized by scanning electron microscope (SEM) and transmission electron microscopy (TEM), whereas mechanical performance of them was understood through tensile test. In vitro degradation rates of the nanofibrous membranes were determined by measuring their height loss when immersed in pH 7.4 phosphate-buffered saline (PBS) mixed with certain amount of Pseudomonas lipase for a maximum of 7 days. The drug release behaviors of the RT and GS were measured using a high performance liquid chromatography (HPLC) and ultraviolet-visible (UV-vis) spectroscopy, respectively. It has been found that the drug solutions without any fiber-forming additive could be encapsulated in the PCL ultrafine fibers, although they alone cannot be made into a fiber form. Beads on the fiber surface influenced the tensile behavior of the ultrafine fibers remarkably. When the core solvent was miscible with the shell solvent, higher drug concentration decreased the bead formation and thus favored the mechanical performance. The situation, however, became different if the two solvents were immiscible with each other. The degradation rate was closely related to hydrophilicity of the drugs in the cores. Higher hydrophilicity apparently led to faster degradation. The release profiles of the RT and GS exhibited a sustained release characteristic, with no burst release phenomenon. (c) 2005 Wiley Periodicals, Inc.

Coaxial Electrospun Poly(L‐Lactic Acid) Ultrafine Fibers for Sustained Drug Delivery

Fabrication of Patterned Three-Dimensional Micron Scaled Core-Sheath Architectures for Drug Patches

Core-shell ultrafine electrospun fibers for drug release applications

A Novel Approach for Tailored Medicines: Direct Writing of Janus Fibers

Electrospun Core-Shell Plla Nanofiber And Its Potential For Drug Release

Encapsulating Drugs in Biodegradable Ultrafine Fibers Through Co-Axial Electrospinning

Study of Electrospun Pllacl Nanofibrous Mats for Drug Delivery System

Nanofiber Prepared by Intermittent Electrospun as Controlled Drug Delivery

Fabrication of Drug-Loaded Electrospun Aligned Fibrous Threads for Suture Applications.

The release kinetic of drug encapsulated poly(L-lactide-co-ɛ-caprolactone) core-shell nanofibers fabricated by emulsion electrospinning

Coaxially Electrospun Core/Shell Structured Poly(L-Lactide) Acid/Chitosan Nanofibers for Potential Drug Carrier in Tissue Engineering

Strategies For Delivering Bioactive Molecules In Electrospun Fibers

Tri-Layer Core–Shell Fibers from Coaxial Electrospinning for a Modified Release of Metronidazole

Electrospun fibers of acid-labile biodegradable polymers with acetal groups as potential drug carriers.

Preparation of Porous Core–Shell Poly L-Lactic Acid/Polyethylene Glycol Superfine Fibres Containing Drug

Electrospun Fibers with Blank Surface and Inner Drug Gradient for Improving Sustained Release.

Electrospinning of Biomacromolecules for Controlled Drug Release

Controlled dual release of hydrophobic and hydrophilic drugs from electrospun poly(l-lactic acid) fiber mats loaded with chitosan microspheres

Fabrication, Characterization and Drug Release Characteristics of Drug Loaded Poly (L-Lactic Acid) Fiber

Preparation and characterization of electrospun PLGA/gelatin nanofibers as a drug delivery system by emulsion electrospinning.

Electrospun Fibre Composite for Controlled Drug Release